LINQ II Adverse Events: FDA MAUDE Data

MEDTRONIC, INC. · Insertable Cardiac Monitor (ICM/ILR) · First cleared Jul 2020 · 5 device variants grouped

Total Reports

10,214

Reports (30d)

209

Active Signals

4

Open Recalls

3

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

Noise Complicating Episode Detection

fibrillation, noise, atrial, episodes, false

79

reports

2

Product Performance Issue Leading to Explant

explanted, insertable cardiac, adverse, effects, service

57

reports

3

Remote Monitoring Network Issues

monitoring network, marks, remote, counters, remote monitoring

56

reports

4

Early Recommended Replacement Time

rrt, recommended replacement, early, time rrt, replacement time

55

reports

5

Multiple Electrical Resets Experienced

use implantable, resets, electrical resets, resets icm, experienced multiple

35

reports

6

Signal Quality Noise Interference

change signal, noise, consistent minor, quality leading, device performing

27

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Active safety signals

ChangepointhighNew problem typehighVolume spikemediumIncreasing trendmedium

FDA recalls for this device

Class II

Nov 3, 2023 · Open, Classified

It may create the potential for amplified noise and/or overall signal reduction of the ICM, which may interfere with intended recordings of heart rhythms. This noise pattern is different from occasional noise due to device position/migration, patient activity, or external electromagnetic interference.

Class II

Jun 1, 2021 · Open, Classified

Reveal LINQ with TruRhythm ICMs, that undergo a partial electrical reset appear to be programmed "ON", but are no longer able to detect and report Brady and Pause events to clinicians.

Class II

May 14, 2021 · Open, Classified

Device fail to detect Brady episodes, Pause (Asystole) episodes and PVC's after a ride-through POR reset.

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 4 active signals detected right now.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.